Male Breast Carcinoma (MBC) is a relatively rare malignant disease, and accounts for about less than 1% of all breast carcinomas, and 0.2% of all malignancies in males.1,2 Approximately 1.2 cases are affected in 100,000 males,3 and are associated with mutation of BRCA1 and BRCA2 genes, with BRCA2 mutation being the most common.4 The gene discussed is BRCA2; the disease is breast carcinoma.